Polymorphisms of Leptin (-2548 G/A) and Leptin Receptor (Q223R) Genes in Iranian Women with Breast Cancer

Recent studies have shown that polymorphisms in leptin and leptin receptor genes are associated with increased risk for breast cancer. This study aimed at investigating -2548 G/A polymorphism in leptin gene and Q223R polymorphism in leptin receptor gene in patients with breast cancer. The study incl...

Full description

Saved in:
Bibliographic Details
Main Authors: Reza Mahmoudi, Bahareh Noori Alavicheh, Mohammad Amin Nazer Mozaffari, Mohammad Fararouei, Mohsen Nikseresht
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:International Journal of Genomics
Online Access:http://dx.doi.org/10.1155/2015/132720
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832562286888222720
author Reza Mahmoudi
Bahareh Noori Alavicheh
Mohammad Amin Nazer Mozaffari
Mohammad Fararouei
Mohsen Nikseresht
author_facet Reza Mahmoudi
Bahareh Noori Alavicheh
Mohammad Amin Nazer Mozaffari
Mohammad Fararouei
Mohsen Nikseresht
author_sort Reza Mahmoudi
collection DOAJ
description Recent studies have shown that polymorphisms in leptin and leptin receptor genes are associated with increased risk for breast cancer. This study aimed at investigating -2548 G/A polymorphism in leptin gene and Q223R polymorphism in leptin receptor gene in patients with breast cancer. The study included 45 women with breast cancer and 41 healthy women. PCR-RFLP was used to determine the genotype of the subjects in terms of -2548 G/A polymorphism in leptin gene and Q223R polymorphism in leptin receptor gene. Serum levels of leptin were also measured by ELISA. For -2548 G/A polymorphism, the genotypes were homozygous AA (OR = 1.13; p=0.8) and heterozygous GA (OR = 0.41; p=0.2) and for Q223R polymorphism, the genotypes were homozygous RR (OR = 6.7; p=0.09) and heterozygous QR (OR = 8.3; p=0.06). The mean serum level of leptin was 33.22 ± 21.35 ng/mL in patients and 29.49 ± 23.27 ng/mL in the normal participants (p=0.3). Although, despite the magnitude of the associations, the results suggested no statistically significant contribution of -2548 G/A polymorphism (in leptin gene), Q223R polymorphism (in leptin receptor gene), and serum leptin levels in predicting the risk of breast cancer, further studies with larger sample size are suggested.
format Article
id doaj-art-cda694d2958f45f9a3a9ecc988150e53
institution Kabale University
issn 2314-436X
2314-4378
language English
publishDate 2015-01-01
publisher Wiley
record_format Article
series International Journal of Genomics
spelling doaj-art-cda694d2958f45f9a3a9ecc988150e532025-02-03T01:23:02ZengWileyInternational Journal of Genomics2314-436X2314-43782015-01-01201510.1155/2015/132720132720Polymorphisms of Leptin (-2548 G/A) and Leptin Receptor (Q223R) Genes in Iranian Women with Breast CancerReza Mahmoudi0Bahareh Noori Alavicheh1Mohammad Amin Nazer Mozaffari2Mohammad Fararouei3Mohsen Nikseresht4Cellular and Molecular Research Center, Yasuj University of Medical Sciences, Yasuj, IranStudents Research Committee, Yasuj University of Medical Sciences, Yasuj, IranCellular and Molecular Research Center, Yasuj University of Medical Sciences, Yasuj, IranHIV/AIDS Research Center, Shiraz University of Medical Sciences, Shiraz, IranCellular and Molecular Research Center, Yasuj University of Medical Sciences, Yasuj, IranRecent studies have shown that polymorphisms in leptin and leptin receptor genes are associated with increased risk for breast cancer. This study aimed at investigating -2548 G/A polymorphism in leptin gene and Q223R polymorphism in leptin receptor gene in patients with breast cancer. The study included 45 women with breast cancer and 41 healthy women. PCR-RFLP was used to determine the genotype of the subjects in terms of -2548 G/A polymorphism in leptin gene and Q223R polymorphism in leptin receptor gene. Serum levels of leptin were also measured by ELISA. For -2548 G/A polymorphism, the genotypes were homozygous AA (OR = 1.13; p=0.8) and heterozygous GA (OR = 0.41; p=0.2) and for Q223R polymorphism, the genotypes were homozygous RR (OR = 6.7; p=0.09) and heterozygous QR (OR = 8.3; p=0.06). The mean serum level of leptin was 33.22 ± 21.35 ng/mL in patients and 29.49 ± 23.27 ng/mL in the normal participants (p=0.3). Although, despite the magnitude of the associations, the results suggested no statistically significant contribution of -2548 G/A polymorphism (in leptin gene), Q223R polymorphism (in leptin receptor gene), and serum leptin levels in predicting the risk of breast cancer, further studies with larger sample size are suggested.http://dx.doi.org/10.1155/2015/132720
spellingShingle Reza Mahmoudi
Bahareh Noori Alavicheh
Mohammad Amin Nazer Mozaffari
Mohammad Fararouei
Mohsen Nikseresht
Polymorphisms of Leptin (-2548 G/A) and Leptin Receptor (Q223R) Genes in Iranian Women with Breast Cancer
International Journal of Genomics
title Polymorphisms of Leptin (-2548 G/A) and Leptin Receptor (Q223R) Genes in Iranian Women with Breast Cancer
title_full Polymorphisms of Leptin (-2548 G/A) and Leptin Receptor (Q223R) Genes in Iranian Women with Breast Cancer
title_fullStr Polymorphisms of Leptin (-2548 G/A) and Leptin Receptor (Q223R) Genes in Iranian Women with Breast Cancer
title_full_unstemmed Polymorphisms of Leptin (-2548 G/A) and Leptin Receptor (Q223R) Genes in Iranian Women with Breast Cancer
title_short Polymorphisms of Leptin (-2548 G/A) and Leptin Receptor (Q223R) Genes in Iranian Women with Breast Cancer
title_sort polymorphisms of leptin 2548 g a and leptin receptor q223r genes in iranian women with breast cancer
url http://dx.doi.org/10.1155/2015/132720
work_keys_str_mv AT rezamahmoudi polymorphismsofleptin2548gaandleptinreceptorq223rgenesiniranianwomenwithbreastcancer
AT baharehnoorialavicheh polymorphismsofleptin2548gaandleptinreceptorq223rgenesiniranianwomenwithbreastcancer
AT mohammadaminnazermozaffari polymorphismsofleptin2548gaandleptinreceptorq223rgenesiniranianwomenwithbreastcancer
AT mohammadfararouei polymorphismsofleptin2548gaandleptinreceptorq223rgenesiniranianwomenwithbreastcancer
AT mohsennikseresht polymorphismsofleptin2548gaandleptinreceptorq223rgenesiniranianwomenwithbreastcancer